Global mRNA Transcriptome Sequencing Market Growth (Status and Outlook) 2025-2031

The global mRNA Transcriptome Sequencing market size is predicted to grow from US$ 4922 million in 2025 to US$ 11730 million in 2031; it is expected to grow at a CAGR of 15.6% from 2025 to 2031.

In molecular biology, messenger ribonucleic acid (mRNA) is a single-stranded molecule of RNA that corresponds to the genetic sequence of a gene, and is read by a ribosome in the process of synthesizing a protein.

Transcriptome sequencing, or RNA sequencing (RNA-Seq), provides fundamental insights into how genomes are organized and regulated—giving us valuable information about the internal state of cells and how altered expression of genetic variants contributes to complex disease research.

• Need for new platforms for accurate RNA data interpretation and advancements made in bioinformatics
• Rise in cases of metabolic disorders, multiple sclerosis, and other diseases
• Growing demand for RNA Sequencing over the conventional technology

are factors that drive the growth of the mRNA sequencing market. In addition, increase in healthcare expenditure; partnerships & collaborations between key players to facilitate development; rise in R&D activities are factors that boost the market growth for mRNA sequencing. However, the need for skilled professionals, the huge initial capital investment on infrastructure, problems associated with the storage of sequencing data are factors that hinder the mRNA sequencing market growth.

This Insight Report provides a comprehensive analysis of the global mRNA Transcriptome Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on mRNA Transcriptome Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global mRNA Transcriptome Sequencing market.

1. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Transcriptome Sequencing
2. It breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity

Segmentation by Type:

• Next Generation Sequencing
• Single Molecule Sequencing
• Others

Segmentation by Application:

• Biomedical Field
• Non-medical Field

This report also splits the market by region:

Americas: United States, Canada, Mexico, Brazil

APAC: China, Japan, Korea, Southeast Asia, India, Australia

Europe: Germany, France, UK, Italy, Russia

Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Company's coverage includes:

• Illumina
• Thermo Fisher Scientific
• Bio-Rad
• Agilent Technologies
• QIAGEN
• Roche
• Pacific Biosciences
• Eurofins Scientific
• Azenta
• LabCorp
• BGI Tech Solutions
• Zhijiang Biology
• Novogene Co.
• Macrogen
• Tsingke Biotechnology
• Oxford Nanopore Technologies
• PerkinElmer, Inc.

Key Questions Addressed in this Report: